U.S Physical Therapy Cash on Hand 2010-2024 | USPH

U.S Physical Therapy cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
U.S Physical Therapy Annual Cash on Hand
(Millions of US $)
2024 $41
2023 $153
2022 $32
2021 $29
2020 $33
2019 $24
2018 $23
2017 $22
2016 $20
2015 $16
2014 $14
2013 $13
2012 $12
2011 $10
2010 $9
2009 $6
U.S Physical Therapy Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $117
2024-06-30 $113
2024-03-31 $132
2023-12-31 $153
2023-09-30 $148
2023-06-30 $161
2023-03-31 $33
2022-12-31 $32
2022-09-30 $38
2022-06-30 $49
2022-03-31 $24
2021-12-31 $29
2021-09-30 $19
2021-06-30 $20
2021-03-31 $18
2020-12-31 $33
2020-09-30 $30
2020-06-30 $44
2020-03-31 $90
2019-12-31 $24
2019-09-30 $28
2019-06-30 $35
2019-03-31 $20
2018-12-31 $23
2018-09-30 $32
2018-06-30 $27
2018-03-31 $20
2017-12-31 $22
2017-09-30 $17
2017-06-30 $20
2017-03-31 $25
2016-12-31 $20
2016-09-30 $15
2016-06-30 $20
2016-03-31 $19
2015-12-31 $16
2015-09-30 $21
2015-06-30 $13
2015-03-31 $15
2014-12-31 $14
2014-09-30 $16
2014-06-30 $13
2014-03-31 $17
2013-12-31 $13
2013-09-30 $12
2013-06-30 $10
2013-03-31 $10
2012-12-31 $12
2012-09-30 $11
2012-06-30 $9
2012-03-31 $10
2011-12-31 $10
2011-09-30 $9
2011-06-30 $9
2011-03-31 $11
2010-12-31 $9
2010-09-30 $10
2010-06-30 $7
2010-03-31 $11
2009-12-31 $6
2009-09-30 $9
2009-06-30 $10
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.298B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00